Rubric Capital Management LP's Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Aug 15, 2025
- Accession no.
- 0000902664-25-003729
- Filed
- Aug 15, 2025, 4:12 PM ET
- Trade date
- Aug 13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $946.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rubric Capital Management LPCIK 0001687509 | 10% Owner |
| Rosen David EfraimCIK 0001898677 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | Common Stock, par value $0.001 per share | SSaleDisposed | −25,000 | $37.85 | −$946,250 | 3,132,743 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.